ClinicalTrials.govpublic full text
Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
esrd, ckd (chronic kidney disease) stage 5d, sglt-2 inhibitors, canagliflozin, ultrafiltration failure, peritoneal fibrosis, peritoneal dialysis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804581
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.